Plug Power Inc vs Stryker Corporation — how do they compare? Plug Power Inc trades at $2.23 (market cap $2.98B), while Stryker Corporation trades at $309.5 (market cap $120.60B). The key difference: Stryker Corporation is far larger — about 40.5× Plug Power Inc's market cap, and Stryker Corporation pays a 1.12% dividend while Plug Power Inc pays none. Which is the better fit depends on your goals.
| PLUG | SYK | |
|---|---|---|
Market Cap | $2.98B | $120.60B |
Sector | Industrials | Technology |
52-Week High | $4.14 | $403.53 |
52-Week Low | $1.40 | $282.58 |
Enterprise Value | $3.77B | $132.36B |
Dividend Yield | — | 1.12% |
Signals from Pluang's Aura AI — not financial advice
Plug Power (PLUG) trades at $2.27, up 5.58% on the day, but remains in a bearish technical trend with oversold RSI readings. The company shows persistent unprofitability with a -227.13% net margin and negative cash flows, though recent earnings have beaten estimates in two of the last three quarters. Positive developments include a 50-megawatt electrolyzer order in Australia and strategic asset sales aimed at boosting liquidity by over $275 million, providing some operational momentum amid financial challenges.
The outlook remains high-risk due to deep losses and cash burn, but analyst consensus is cautiously optimistic with a $2.92 price target (28% upside). Investment opportunity hinges on successful turnaround execution and hydrogen demand growth, while key risks include continued dilution, competitive pressure, and reliance on financing to fund operations. The stock's depressed valuation reflects significant skepticism, leaving room for volatility on news flow.
Stryker (SYK) trades at $319.14, down 0.23% with a bearish technical signal despite strong fundamentals. The company reported $25.12B revenue and $3.25B net income for 2025, maintaining robust margins. Recent news highlights Mako RPS launch expansion in robotic surgery, while Q1 2026 earnings missed expectations due to a temporary cyber disruption, though full-year guidance remains unchanged.
Outlook remains positive with 74% analyst buy ratings and a $388.44 consensus price target implying 22% upside. Key risks include competitive pressures and execution challenges from recent cybersecurity issues. The stock presents a growth opportunity in med-tech innovation, trading below historical valuation multiples with healthy cash flow generation.
Trailing returns across standard periods
Latest headlines on both assets
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets—including material handling, e-mobility, power generation, and industrial applications.
Read more on PLUG →Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →